Cardiac Critical Care
M-A | Techniques improving electrical cardioversion success for patients with atrial fibrillation
10 Jan, 2023 | 14:12h | UTC
The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischemic heart disease
9 Jan, 2023 | 14:28h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardiovascular Imaging https://t.co/OVJxxYu71p@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #cvimaging @chiarabd @NAjmoneMarsan pic.twitter.com/sooF0bz3LN
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
Left heart catheterization complications | ED presentations, evaluation, and management
9 Jan, 2023 | 14:07h | UTCLeft Heart Catheterization Complications: ED Presentations, Evaluation, and Management – emDocs
M-A | Predicting neurological outcome in adult patients with cardiac arrest.
14 Dec, 2022 | 15:02h | UTC
Consensus Paper | Evaluation and management of cancer patients presenting with acute cardiovascular diseases.
9 Dec, 2022 | 13:28h | UTCRelated:
The ‘Ten Commandments’ for the 2022 European Society of Cardiology guidelines on cardio-oncology.
#ESCCongress | 2022 ESC Guidelines on cardio-oncology.
Brazilian Cardio-oncology Guideline – 2020 – Arquivos Brasileiros de Cardiologia
RCT | Utility of coronary CT angiography for patients with suspected acute coronary syndrome.
9 Dec, 2022 | 13:22h | UTCProspective RandOmised Trial of Emergency Cardiac Computerised Tomography (PROTECCT) – Heart
Commentary on Twitter
PROTECCT Trial @Heart_BMJ shows that immediate coronary CT in ED does not reduce length of stay in patients with suspected #AcuteCoronarySyndrome that cannot be ruled in/out on first #Troponin. @TheBHF @kingscardio @KingsImaging @GSTTresearch https://t.co/ud4rxEpmKl pic.twitter.com/YmKXFWIBZd
— Cardiac Research (@UKheartresearch) October 27, 2022
Under a http://creativecommons.org/licenses/by-nc/4.0/ License
Review | How to assess systemic venous congestion with point of care ultrasound.
6 Dec, 2022 | 13:37h | UTC
2022 International Consensus on CPR and emergency cardiovascular care science with treatment recommendations.
5 Dec, 2022 | 00:25h | UTC
Review | Contemporary management of concomitant cardiac arrest and cardiogenic shock complicating myocardial infarction.
2 Dec, 2022 | 14:11h | UTC
RCT | Combining loop with thiazide diuretics for decompensated heart failure.
1 Dec, 2022 | 14:02h | UTC
Commentary on Twitter
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial https://t.co/wGfKpo03H6 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/VfnQnp2AKa
— European Society of Cardiology Journals (@ESC_Journals) November 30, 2022
Review | Thrombolysis in cardiac arrest.
29 Nov, 2022 | 14:08h | UTCThrombolysis in Cardiac Arrest – emDocs
2ry analysis of a RCT | Decongestion with acetazolamide in acute heart failure across the spectrum of left ventricular EF.
25 Nov, 2022 | 12:45h | UTCOriginal Study: RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.
Commentary on Twitter
#OriginalResearch simpub #AHA2022 #CIRCAHA22: Acetazolamide added to loop diuretics ⬆️ likelihood of successful decongestion similarily in patients with HFrEF, HFmrEF and HFpEF. Data from the #ADVOR trial. @PieterMartensMD @WilfriedMullens #AHAJournals https://t.co/MkISN2H1vA pic.twitter.com/qFjCKdRaF6
— Circulation (@CircAHA) November 6, 2022
SR | Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
24 Nov, 2022 | 13:24h | UTC
RCT | Impact of empagliflozin on decongestion in acute heart failure.
23 Nov, 2022 | 14:04h | UTCCommentary: Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE – American College of Cardiology
Commentary on Twitter
What's the impact of empagliflozin on decongestion in acute heart failure? New insights from the EMPULSE trial in EHJ!https://t.co/O1MZTFPWCc#SGLT2 #decongestion #heartfailure #empagliflozin #cardiotwitter @escardio @ESC_Journals pic.twitter.com/QLJYNgl1Zo
— EHJ Editor-in-Chief (@ehj_ed) October 19, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A | Lower vs. higher exposure to vasopressor therapy in vasodilatory hypotension.
21 Nov, 2022 | 14:16h | UTC
Review | POCUS for aortic dissection in the clinical presentation of ischemic stroke.
17 Nov, 2022 | 12:08h | UTCPOCUS for aortic dissection in the clinical presentation of ischemic stroke – emDocs
RCT | Bivalirudin is superior to heparin in patients with ST-segment elevation myocardial infarction undergoing primary PCI.
15 Nov, 2022 | 13:00h | UTCCommentaries:
BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI – TCTMD
RCT | Early routine use of ECMO fails to improve outcomes in patients with cardiogenic shock.
11 Nov, 2022 | 14:01h | UTCCommentaries:
Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock – TCTMD
Immediate Use of ECMO Did Not Improve Outcomes in Patients with Cardiogenic Shock – HCP Live
Commentary on Twitter
#OriginalResearch simpub #AHA2022: In this #RCT immediate implementation of VA-ECMO in patients with cardiogenic shock did not improve clinical outcomes compared with an early conservative strategy which allowed downstream use of… #CIRCAHA22 #AHAJournals https://t.co/03qVyC0Vgl pic.twitter.com/WRNDsAZfpD
— Circulation (@CircAHA) November 6, 2022
Review | Diagnosis of cardiac surgery-associated acute kidney injury.
10 Nov, 2022 | 13:27h | UTCRelated:
Clinical practice update for management of acute kidney injury associated with cardiac surgery.
RCT | Using an algorithm to stratify the risk of patients with acute heart failure may improve outcomes.
9 Nov, 2022 | 12:30h | UTCTrial of an Intervention to Improve Acute Heart Failure Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events – TCTMD
Commentary on Twitter
The use of a validated tool for risk assessment, combined with rapid follow-up, led to a lower risk of death or hospitalization for cardiovascular causes at 30 days among patients with acute heart failure. #AHA22 https://t.co/0cbvcHl3US pic.twitter.com/kpWbRGpOJX
— NEJM (@NEJM) November 5, 2022
RCT | New defibrillation strategies increased the rates of survival to hospital discharge in patients with refractory ventricular fibrillation.
8 Nov, 2022 | 12:27h | UTCDefibrillation Strategies for Refractory Ventricular Fibrillation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: “Double shock” from two defibrillators could save more lives – Heart & Stroke
Commentary on Twitter
In a trial involving patients with refractory ventricular fibrillation, double sequential external defibrillation or vector-change defibrillation improved survival as compared with standard defibrillation. #AHA22 https://t.co/2l2t9iGnwq pic.twitter.com/SzVU93OsrX
— NEJM (@NEJM) November 6, 2022
RCT | Rapid up-titration of guideline-directed medical therapies for acute heart failure reduced readmissions and deaths.
8 Nov, 2022 | 12:24h | UTCSafety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial – The Lancet (free registration required)
News Release: Maximizing heart failure meds within 2 weeks reduced risk of hospital readmission, death – American Heart Association
Commentary: STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends – TCTMD
RCT | After an out-of-hospital cardiac arrest, fever prevention for 36 vs. 72 hours resulted in similar outcomes.
8 Nov, 2022 | 12:23h | UTCDuration of Device-Based Fever Prevention after Cardiac Arrest – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In this trial involving patients after out-of-hospital cardiac arrest, fever prevention for 36 or 72 hours did not result in different percentages of patients dying or having severe disability or coma. #AHA22 https://t.co/Cx6x4RfqCE pic.twitter.com/vGSb0iVISN
— NEJM (@NEJM) November 6, 2022
Review | Targeted temperature management in postresuscitation care after incorporating results of the TTM2 Trial.
8 Nov, 2022 | 12:09h | UTCRelated:
Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial – Circulation
Hypothermic versus Normothermic Temperature Control after Cardiac Arrest – NEJM Evidence
ERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (if the link is paywalled, try this one)
Review | Optimal perfusion targets in cardiogenic shock.
31 Oct, 2022 | 13:45h | UTCOptimal Perfusion Targets in Cardiogenic Shock – JACC: Advances
Commentary on Twitter
#CardiogenicShock (CS) carries marked morbidity and mortality, w/ limited data to guide hemodynamic targets. Randomized #clinicaltrials in CS subsets are necessary to better elucidate optimal #perfusion targets. https://t.co/XpmXmlMdww#JACCAdvances #resuscitation #CardioTwitter pic.twitter.com/VWDEYkQ3nm
— JACC Journals (@JACCJournals) July 4, 2022